2017 was a year of big FDA changes for labs that mill custom implant abutments. Kim Karpowitz takes you through the experience of a number of high-profile labs that faced this controversy head-on, what the FDA had to say, and what's been learned that can dramatically streamline the process of full FDA compliance.